Interestingly, recent studies reported that HDAC inhibitors reduced MDSCs function – a major immunosuppressive cell in the tumor microenvironment and promoted anti-tumor immune responses (59, 60, 76). This evidence concerns the gene HDAC9 and neoplasm.